Sector
PharmaceuticalsOpen
₹52.04Prev. Close
₹49.58Turnover(Lac.)
₹0.46Day's High
₹52.04Day's Low
₹48.4752 Week's High
₹79.2352 Week's Low
₹31.79Book Value
₹20.14Face Value
₹10Mkt Cap (₹ Cr.)
170.94P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 21.79 | 10.27 | 10.27 | 10.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 0.63 | -1.6 | -1.74 | -1.84 |
Net Worth | 22.42 | 8.67 | 8.53 | 8.43 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 3.93 | 8.55 | 0 | 0.44 |
yoy growth (%) | -53.93 | 0 | -100 | -62.64 |
Raw materials | -3.57 | -8.15 | 0 | -0.49 |
As % of sales | 90.66 | 95.41 | 0 | 110.08 |
Employee costs | -0.04 | -0.04 | -0.02 | -0.06 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 0.14 | 0.08 | -0.37 | -0.36 |
Depreciation | 0 | -0.04 | -0.03 | 0 |
Tax paid | 0 | 0 | 0.4 | -0.01 |
Working capital | -0.05 | -0.09 | -0.16 | -0.62 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -53.93 | 0 | -100 | -62.64 |
Op profit growth | 28.21 | -131.86 | -13.1 | 12.42 |
EBIT growth | 61.7 | -123.62 | 1.95 | -7.53 |
Net profit growth | 55.54 | 178.26 | -108.69 | -451.66 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 |
---|---|---|
Gross Sales | 15.11 | 0 |
Excise Duty | 0 | 0 |
Net Sales | 15.11 | 0 |
Other Operating Income | 0 | 0 |
Other Income | 0.88 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
E D & Wholetime Director
Venu Madhava Kaparthy
E D & Wholetime Director
Mini Manikantan
Non-Exec & Non-Independent Dir
Sadhanala Venkata Rao
Independent Non Exe. Director
P N Vijay
Independent Non Exe. Director
M Sudheer Anand
Independent Non Exe. Director
Methuku Nagesh
Additional Director
Shreedhara Shetty
Chairman & Director
Shankarappa Nagaraja Vinaya Babu
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Pharmaids Pharmaceuticals Ltd
Summary
Pharmaids Pharmaceuticals Ltd is a public limited company incorporated on 01st March 1989. The Company is primarily engaged in business of manufacturing of bulk drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation. In FY19, the proposed Scheme of Amalgamation of M/s. Emergent Bio Naturals Ltd (Transferor Company) into M/s. Pharmaids Pharmaceuticals Ltd (Transferee Company) pursuant to section 230 to 232 of the Companies Act, 2013 is pending for approval before the NCLT, Hyderabad Bench.
Read More
The Pharmaids Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹48.47 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pharmaids Pharmaceuticals Ltd is ₹170.94 Cr. as of 22 Jul ‘24
The PE and PB ratios of Pharmaids Pharmaceuticals Ltd is 0 and 2.46 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Pharmaids Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Pharmaids Pharmaceuticals Ltd is ₹31.79 and ₹79.23 as of 22 Jul ‘24
Pharmaids Pharmaceuticals Ltd's CAGR for 5 Years at 58.60%, 3 Years at 43.44%, 1 Year at 11.87%, 6 Month at -19.16%, 3 Month at -23.46% and 1 Month at -3.69%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.